Top Healthcare companies in Canada by Price to Sales Ratio (P/S)

This ranking features the top 18 Healthcare companies in Canada ranked by Price to Sales Ratio (P/S), averaging a Price to Sales Ratio (P/S) of 3.03, for February 06, 2025.
#
Name
Price to Sales Ratio (P/S)
Reported Date
Stock Price
Change
Price (30 days) Country
1

74.60

Feb. 5, 2025 USD 0.15 -5.56%

Canada

2

25.97

Feb. 5, 2025 USD 6.23 -0.19%

Canada

3

11.50

Feb. 5, 2025 USD 9.51 -0.80%

Canada

4

1.87

Feb. 5, 2025 USD 4.39 2.76%

Canada

5

1.63

Feb. 5, 2025 USD 4.00 3.39%

Canada

6

1.58

Feb. 5, 2025 USD 11.31 1.91%

Canada

7

1.49

Feb. 5, 2025 USD 2.96 1.10%

Canada

8

0.97

Feb. 5, 2025 USD 5.33 -0.12%

Canada

9

0.92

Feb. 5, 2025 USD 64.97 1.17%

Canada

10

0.86

Feb. 5, 2025 USD 1.52 2.02%

Canada

11

0.85

Feb. 5, 2025 USD 125.74 -0.23%

Canada

12

0.76

Feb. 5, 2025 USD 2.65 -1.93%

Canada

13

0.67

Feb. 5, 2025 USD 7.91 7.55%

Canada

14

0.61

Feb. 5, 2025 USD 2.82 1.40%

Canada

15

0.60

Feb. 5, 2025 USD 11.59 0.75%

Canada

16

0.45

Feb. 5, 2025 USD 156.50 -0.56%

Canada

17

0.39

Feb. 5, 2025 USD 3.84 1.43%

Canada

18

0.36

Feb. 5, 2025 USD 1.59 1.49%

Canada

Frequently Asked Questions
  • Which Healthcare company in Canada has the highest Price to Sales Ratio (P/S) ?

    The Healthcare company in Canada with the highest Price to Sales Ratio (P/S) is Ondine Biomedical Inc. (LSE: OBI.L) at 74.60.

  • Which Healthcare company in Canada has the lowest Price to Sales Ratio (P/S) ?

    The Healthcare company in Canada with the lowest Price to Sales Ratio (P/S) is CareRx Corporation (Toronto Stock Exchange: CRRX.TO) at 0.36.

SV Wall Street